Pruzanski Mark — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Pruzanski Mark has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Mark Pruzanski is connected to Equillium, Inc. in the 2026-05-29 SEC filings, indicating an affiliation with the biopharmaceutical company. The specific role or title is not provided in the available context. Equillium is a clinical-stage biotech focused on immune-mediated diseases. Public biographical information for this individual is limited beyond SEC disclosures; there is no confirmed public record of his death as of the filing date, and no widely known Wikipedia/Wikidata entry identified from major sources. This entry is based on the SEC filing context only.
Mark Pruzanski is connected to Equillium, Inc. in the 2026-05-29 SEC filings, indicating an affiliation with the biopharmaceutical company. The specific role or title is not provided in the available context. Equillium is a clinical-stage biotech focused on immune-mediated diseases. Public biographical information for this individual is limited beyond SEC disclosures; there is …
How many SEC Form 4 filings has Pruzanski Mark submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Pruzanski Mark's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
